Abstract The tumors of dendritic/reticulum cells constitutes the rarest tumors affecting the lymphoid tissues. Among them tumors derived from fibroblastic reticular cells (FBRCs) are very rare, and those of cytokeratin (CK)-positive interstitial reticulum cells (CIRCs) origin are even more rare. These tumors can be easily misdiagnosed as tumors of other dendritic cells, myofibroblastic tumors or even metastatic poorly differentiated carcinomas. Less than twenty such cases have been reported in the literature till date. We present such a rare case of CIRC sarcoma in cervical lymph node of a 64-year-old man.
Introduction

Lymph nodes contain nonlymphoid accessory dendritic/ reticulum cells including follicular dendritic cells (FDCs), interdigitating dendritic cells (IDCs), Langerhans cells (LCs)
and fibroblastic reticular cells (FBRCs). Cytokeratin (CK)-positive interstitial reticulum cells (CIRCs) are considered to represent a subset of FBRCs. Although the tumors of dendritic/reticulum cells constitutes the rarest tumors affecting the lymphoid tissues, the neoplasms derived from the first three cell types are well documented and relatively known entities. Tumors derived from FBRCs are very rare, and those of CIRC origin are even more rare [1, 2] . They are easily misdiagnosed as tumors originating from other accessory dendritic cells, myofibroblasts or even metastatic poorly differentiated carcinomas due to their similar histomorphologic features [3] . Extensive review of the literature reveals only nineteen cases of FBRC tumors (FBRCTs) including 4 cases of CK-negative FBRCTs, 14 cases of CIRC tumors (CIRCTs) and one case of mixed tumor with dendritic and fibroblastic features, reported till date (Table 1) . We report an additional case of CIRCT in cervical lymph node of a 64-year-old man.
Case Report
A 64-year-old male presented with gradually increasing painless swelling in the right submandibular region for last three months without any history of associated rise of temperature. There was no improvement with three courses oral antibiotics which was prescribed by his family physician. On clinical examination, three enlarged painless firm mobile lymph nodes were observed in right submandibular, mid cervical and supraclavicular regions. Out of these three lymph nodes mid cervical lymph node was the largest one. No other relevant abnormality was detected on clinical examination. On routine hematological investigation, his hemoglobin level was 13.2 g/ dL, total white blood cell count was 6,700/mm 3 and RBCs displayed normocytic normochromic features on peripheral blood film examination. The erythrocyte sedimentation rate (ESR) was 40 mm after the 1st hour and platelet count was 3 . All other routine biochemical examinations were within normal limit. Ultrasonography demonstrated large heterogeneous mass with punctuated calcification in right side of neck. Lymphoproliferative lesion was suspected on fine needle aspiration cytology (FNAC) examination and urgent biopsy was suggested to confirm the diagnosis.
Histopathological examination was carried out on formalin-fixed, paraffin-embedded tissue sections prepared from excisional biopsy specimen of the right mid cervical lymph node. Grossly, the resected lymph node measuring 6.0 cm× 5.0 cm×4.5 cm was grayish to tan on the cut surface and uniformly solid in texture. It appeared to have a complete capsule. Histologically, the nodal architecture was almost completely effaced by a neoplastic proliferation that focally infiltrated contiguous soft tissues. A rim of compressed residual normal lymphoid tissue was observed in the subcapsular area. Neoplastic growth mostly consisted of diffuse sheets of medium to large polygonal epithelioid cells having large vesicular nuclei, prominent central eosinophilic nucleoli and abundant eosinophilic cytoplasm with indistinct cell borders resulting in a syncytial appearance (Fig. 1) . Scattered multinucleated giant cells with irregular to multilobated, hyperchromatic nuclei and prominent nucleoli were found Immunostaining was performed by applying the streptavidin-biotin-peroxidase-conjugate method in an automated stainer (Ventana BenchMark XT, Ventana Medical Systems, Rosche) utilizing the manufacturer's protocol with prediluted ready-to-use antibodies (Dako, Glostrup, Denmark). Immunohistochemistry revealed diffuse positive reaction of the tumor cells for vimentin (V9) (Fig. 2) , smooth muscle actin (1A4) (Fig. 3) , CD68 (PG-M1) (Fig. 4) and cytokeratin AE1/AE3 (AE1/AE3) (Fig. 5) . The neoplastic cells were negative for S-100 (polyclonal), CD45 (2B11+PD7/26), CD3 (polyclonal), CD20 (L26), CD21 (1 F8), CD23 (DAK-CD23), EMA (E29), ALK-1 (ALK1), HMB-45 (HMB-45), CD34 (QBEnd 10) and desmin (D33). Ki-67 (MIB-1) index was 60 % (Fig. 6) . The background lymphocytes displayed the positive staining with CD3 and CD45. Considering the immunohistochemical profile we arrived at the diagnosis of cytokeratin-positive interstitial reticulum cell sarcoma. As the patient died within two weeks of the final diagnosis no follow up data is available with us.
Discussion
CIRCs were first described in normal lymph nodes by Franke and Moll in the year 1987. They are indigenous to lymphoid organs, originate from mesenchymal stem cells, express cytokeratin and are considered as a subset of FBRCs. Some of these CIRCs coexpress SMA and desmin. They have long, slender cytoplasmic processes extending between lymphocytes and are found in the extrafollicular T cell compartment of lymph nodes in the outer and inner cortex and the medulla, particularly along small blood vessels. They also have been identified in the extrafollicular areas of the spleen and in the tonsils. Ultrastructurally, these cells contain abundant intermediate filaments in the perinuclear cytoplasm and cytoplasmic processes and tonofilament like tight bundles [2, 4] . Gould et al. [5] should be credited for first raising the possibility of the existence of a CIRC tumor.
CIRC sarcomas need to be distinguished from poorly differentiated carcinomas, tumors derived from other accessory Fig. 3 Immunostaining of neoplastic cells with SMA (×400) Fig. 4 Immunostaining of neoplastic cells with CD68 (×400) Fig. 5 Immunostaining of neoplastic cells with cytokeratin AE1/AE3 (×400) Fig. 6 Immunostaining of neoplastic cells with Ki67 (×400) dendritic cells (FDC and IDC sarcomas) , myofibroblasts, and malignant mesenchymal tumors (i.e., various sarcomas, sarcomatoid variant of anaplastic large-cell lymphoma and malignant melanoma) as they have no characteristic clinical symptoms or histological features [2, 6] . The lack of awareness of these tumors or their expression of cytokeratin and epithelioid morphology lead to a misdiagnosis of metastatic carcinoma, particularly when they are of nodal origin in patients with known carcinoma [2, 4, 7] . All such histologic mimickers have to be eliminated by combining careful light microscopic analysis with the immunohistochemical and/or ultrastructural data and the clinical details [6, 8] .
FBRCs including CIRCs are immunohistochemically reactive for vimentin, SMA, CD68 and variably for desmin and negative for FDC markers like CD21, CD23, CD35 and KiM4p, IDC and LC marker S-100, lymphoid markers CD45, CD3, CD20 and melanoma marker HMB-45. Further negativity for both desmin and anaplastic lymphoma kinase (ALK) is helpful to exclude an inflammatory myofibroblastic tumor [6, 8, 9] . Most of these immunohistochemical features support the diagnosis of CIRCT in the present tumor with epithelioid cell morphology.
Other than pure FBRCTs or CIRCTs Jones et al. [10] reported a case of reticulum cell sarcoma with mixed dendritic and fibroblastic features, Kakiuchi et al. [11] described a case of CIRCT with Castleman's disease and Suárez et al. [12] found a case of CIRCT coincidentally with an undifferentiated endometrial stromal sarcoma.
As the role of adjuvant chemotherapy and radiotherapy is not clearly defined surgical excision remains the primary mode of treatment in CIRCTs. Prognosis of CIRC sarcomas is difficult to establish due to its variable biologic behavior and limited number of cases [2] . Hence, it needs further future evaluation to provide comprehensive data on this entity.
